Work

Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents

Year: 2019

Type: article

Study design: Observational Study

Source: Journal of the American Academy of Child & Adolescent Psychiatry

DOI: 10.1016/j.jaac.2019.06.010

Authors: Laura Ghirardi, Henrik Larsson, Zheng Chang, Qi Chen, Patrick D. Quinn, Kwan Hur, Robert D. Gibbons, Brian M. D’Onofrio

Institutions: Karolinska Institutet, Örebro University, Indiana University Bloomington, Indiana University, University of Chicago

Language: English

Topic: Attention Deficit Hyperactivity Disorder

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Justice, Pfizer, GlaxoSmithKline, Merck, Shire, Vetenskapsrådet, National Institutes of Health, National Institute of Mental Health, National Institute on Drug Abuse

Awards: Pharmacoepidemiologic Studies of Prescription Opioid Analgesic Risks, G263769737, G2965175503, G6153242990, Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems, Pharmacoepidemiologic Studies of Prescription Opioid Analgesic Risks

OpenAlex ID: W2959936147

FWCI: 4.382

Cites: 32

Cited by: 36

Related to: 10